Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Brigitte Sigal-Zafrani
Based on 34 articles published since 2009
(Why 34 articles?)
||||
Expertise Level
The expertise of Brigitte Sigal-Zafrani ranks in the
  • Top 0.9%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 34 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Sigal-Zafrani, Brigitte   ·   Sigal-Zafrani, B
Work Locations
Details
Most likely:    Institut Curie      
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Department of Surgery, Institut Curie, Paris, France. · Translational Research Department, RT2Lab Team, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Clinical Epidemiology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 28241044
2016
  • Department of Biostatistics, Institut Curie, Paris, France. · Pharmacogenomics Unit, Department of Genetics, Institut Curie, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Biology Department, Institut Gustave Roussy, Villejuif, France. · APHP Pathology Department, Hôpital Saint Louis, Paris Diderot University, Paris, France. · Pathology Department, Hôpital René-Huguenin, Institut Curie, Saint-Cloud, France. · Pathology Department, Institut Gustave Roussy, Villejuif, France. · Pathology Department, Institut Curie, Paris, France. · APHP, Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Pubmed 27592112
  • Institut E3M-ICAN, Department of Endocrinology and Reproductive Medicine (Z.C., C.C., V.Gr., I.T., P.T.), Hôpitaux Universitaires Pitié Salpêtrière Charles Foix, Centre des Pathologies Gynécologiques Rares, Firendo, Université Pierre et Marie Curie, 75013 Paris, France · Department of Oncological Surgery (F.L.), Institut Curie, 75005 Paris, France · Inserm (M.B., I.C., A.C., N.P., S.B., F.B., P.C., J.-E.G., V.G., P.T.), U1151, Institut Necker Enfants Malades, 75993 Paris, France · Université Paris Descartes (M.B., I.C., A.C., N.P., S.B., F.B., M.F., M.D.C., R.P., J.-E. G., V.G.), Sorbonne Paris Cité, France · Department of Genetics (I.B., S.V.), Institut Curie, 75005 Paris, France · Unite de Recherche Clinique (M.-L.T., A.B.), Pitie Salpêtriere Hospital, 75013 Paris, France · Inserm (M.F., M.D.C.), U1016, Institut Cochin, 75014 Paris, France · CNRS (M.F., M.D.C., R.P.), UMR8104, Paris, France · Inter Régional pour la Santé (F.R., J.T.), La Riche, France · and Department of Pathology (B.S.-Z.), Institut Curie, 75005 Paris, France. · Pubmed 27575941
  • Translational Research Department, Laboratory of Preclinical Investigation, Institut Curie, PSL University, Paris, France. · Institut Roche, Boulogne-Billancourt, France. · Department of Pathology, Institut Curie, Paris, France. · Platform of Molecular Biology Facilities, Institut Curie, PSL University, Paris, France. · Flow Cytometry Core Facility, Institut Curie, PSL University, Paris, France. · GenoSplice Technology, Institut Universitaire d'Hématologie, Paris, France. · Inserm, U830, Institut Curie, PSL University, Paris, France. · CNRS UMR3306, INSERM U1005, Institut Curie, PSL University, Orsay, France. · Department of Medical Oncology, Institut Curie, Institut Curie, Paris, France. · Roche Diagnostics GmbH, Penzberg, Germany. · Translational Research Department, Institut Curie, PSL University, Paris, France. · Pubmed 27388901
  • Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Translational Research, Institut Curie, Paris, France. · QIAGEN Marseille SA, Marseille, France. · Residual Tumor and Response to Treatment Team, Institut Curie, Department of Translational Research, Paris, France. · Pubmed 26829108
  • Centre De Recherche, Institut Curie, Paris, F-75248, France. · INSERM U830, Paris, F-75248, France. · Département De Biologie Des Tumeurs, Institut Curie, Paris, F-75248, France. · Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, K7L 3N6, Canada. · Centre De Ressources Biologiques, Institut Curie, Paris, F-75248, France. · Département De Recherche Translationnelle, Institut Curie, Paris, F-75248, France. · Sorbonne Paris Cité, University Paris-Descartes, Paris, F-75270, France. · Pubmed 26317927
  • Psycho-Oncology Unit, Supportive Care Department, Institute Curie, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · Psychology Institute, LPPS EA 4057, University Paris Descartes, Boulogne Billancourt, France. · EA 4275, Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Sciences, University of Nantes, Nantes, France. · Institute of High School in Osteopathy, Laboratory of Osteopathy Research, Nantes, France. · Tumor Biology Department, Institut Curie, Paris, France. · Psycho-Oncology Unit, Supportive Care Department, Institute Curie, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · Psychology Institute, LPPS EA 4057, University Paris Descartes, Boulogne Billancourt, France. · Inserm, U 669, Paris, France. · University Paris-Sud and UMR-S0669, University Paris Descartes, Paris, France. · Unit of Methodology and Biostatistics, University Hospital of Nantes, Nantes, France. · Pubmed 26076962
2015
  • INSERM U932, Institut Curie, Paris, France. Institut Curie, Department of Immunology, Paris, France. · UMR144 CNRS, Institut Curie, Paris, France. Institut Curie, Department of Surgical Oncology, Paris, France. · Université Lyon 1, Lyon, France. INSERM U1052/CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Centre Léon Bérard, Lyon, France. · Institut Curie, Department of Pathology, Paris, France. · Institut Curie, Department of Surgical Oncology, Paris, France. · INSERM U932, Institut Curie, Paris, France. Institut Curie, Department of Immunology, Paris, France. Center of Clinical Investigations, Curie-IGR, Paris-Villejuif, France. · Pubmed 25977333
  • Psycho-Oncology Unit, Supportive Care Department, Institute Curie, Paris, France. · Psychology Institute, LPPS EA 4057, University Paris Descartes, Paris, France. · Inter-Psy, Lorraine University, Nancy, France. · Tumour Biology Department, Institut Curie, Paris, France. · Inserm, Paris, France. · University Paris-Sud and UMR-S0669, Paris, France. · University Paris Descartes, Paris, France. · Pubmed 25976423
2014
  • Centre for Computational Biology, Mines ParisTech, Fontainebleau, France; Institut Curie, Paris, France; U900, INSERM, Paris, France. · UMR144, Oncology Molecular Team, Institut Curie, Paris, France; Department of translational research, Residual Tumor and Response to Treatment Team, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Radiotherapy, Institut Curie, Paris, France. · UMR144, Oncology Molecular Team, Institut Curie, Paris, France; Department of translational research, Residual Tumor and Response to Treatment Team, Institut Curie, Paris, France; Department of Surgery, Institut Curie, Paris, France. · Pubmed 25098247
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Department of Radiology, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 24714751
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Radiology, Institut Curie, Paris, France. · Department of Tumors' Biology, Institut Curie, Paris, France. · Department of Radiotherapy, Institut Curie, Paris, France. · Pubmed 24388733
2013
  • Department of Biostatistics, Curie Institute, Paris 75248, France; Inserm U900, Curie Institute, Paris 75248, France. · Pubmed 24095610
  • Institut Curie, Centre de Recherche, Paris, France; INSERM U830, Paris, France; Department of Tumor Biology, Institut Curie, Paris, France. · Pubmed 23754601
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23526930
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23051951
2012
  • Department of Tumor Biology, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France. · Pubmed 22711610
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 21907436
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23056641
  • Department of Tumor Biology, Institut Curie, 26 rue d'ULM, 75248 Paris Cedex 05, France. · Pubmed 22531230
  • Département de chirurgie, Institut Curie, Paris, France. · Pubmed 22529987
  • Department of Radiation Oncology, Institut Curie, 26 rue d'Ulm, Paris, 75005, France. · Pubmed 22438050
  • Institut Curie, CNRS, Paris, France. · Pubmed 22271875
  • Department of Medical Oncology, Institut Curie, 26 rue d’Ulm, Paris Cedex 05, France. · Pubmed 21358298
2011
  • Department of tumour Biology, Institut Curie, Paris 75005, France. · Pubmed 21631949
  • Department of Biostatistics, Institut Curie, Paris, France. · Pubmed 22087319
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 21655258
2010
  • Preclinical Investigation Unit, Institut Curie - Translational Research Department, Hôpital St Louis, Quadrilatère historique, Porte 13, 1, Ave Claude Vellefaux, Paris 75010, France. · Pubmed 20877358
Probable:    INSERM France      
2016
  • Translational Research Department, Laboratory of Preclinical Investigation, Institut Curie, PSL University, Paris, France. · Institut Roche, Boulogne-Billancourt, France. · Department of Pathology, Institut Curie, Paris, France. · Platform of Molecular Biology Facilities, Institut Curie, PSL University, Paris, France. · Flow Cytometry Core Facility, Institut Curie, PSL University, Paris, France. · GenoSplice Technology, Institut Universitaire d'Hématologie, Paris, France. · Inserm, U830, Institut Curie, PSL University, Paris, France. · CNRS UMR3306, INSERM U1005, Institut Curie, PSL University, Orsay, France. · Department of Medical Oncology, Institut Curie, Institut Curie, Paris, France. · Roche Diagnostics GmbH, Penzberg, Germany. · Translational Research Department, Institut Curie, PSL University, Paris, France. · Pubmed 27388901
2013
  • Department of Biostatistics, Curie Institute, Paris 75248, France; Inserm U900, Curie Institute, Paris 75248, France. · Pubmed 24095610
  • Institut Curie, Centre de Recherche, Paris, France; INSERM U830, Paris, France; Department of Tumor Biology, Institut Curie, Paris, France. · Pubmed 23754601
  • Institut National de la Santé et de la Recherche Medicale (Inserm), U1016, Institut Cochin, France. · Pubmed 23396587
2012
  • INSERM, Centre d'Investigations Cliniques-9501, CHU Nancy & Nancy-Université, 54511 Vandoeuvre-les-Nancy, France. · Pubmed 22048814
Probable:    Sorbonne University      
2016
  • Translational Research Department, Laboratory of Preclinical Investigation, Institut Curie, PSL University, Paris, France. · Institut Roche, Boulogne-Billancourt, France. · Department of Pathology, Institut Curie, Paris, France. · Platform of Molecular Biology Facilities, Institut Curie, PSL University, Paris, France. · Flow Cytometry Core Facility, Institut Curie, PSL University, Paris, France. · GenoSplice Technology, Institut Universitaire d'Hématologie, Paris, France. · Inserm, U830, Institut Curie, PSL University, Paris, France. · CNRS UMR3306, INSERM U1005, Institut Curie, PSL University, Orsay, France. · Department of Medical Oncology, Institut Curie, Institut Curie, Paris, France. · Roche Diagnostics GmbH, Penzberg, Germany. · Translational Research Department, Institut Curie, PSL University, Paris, France. · Pubmed 27388901
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 34 total) written by Brigitte Sigal-Zafrani about Breast Neoplasms:

  • Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status. 2017
  • Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers. 2017
  • BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy. 2016
  • Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma Risk. 2016
  • Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization. 2016
  • Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay. 2016
  • Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas. 2016
  • Identifying trajectory clusters in breast cancer survivors' supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later. 2016
  • Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes. 2015
  • Breast cancer survivors' perceived medical communication competence and satisfaction with care at the end of treatment. 2015
Show List of Full Article Records
Google Searches

Learn more about Brigitte Sigal-Zafrani using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Curie
INSERM France
Sorbonne University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Curie
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Department of Surgery, Institut Curie, Paris, France. · Translational Research Department, RT2Lab Team, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Clinical Epidemiology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 28241044
2016
  • Department of Biostatistics, Institut Curie, Paris, France. · Pharmacogenomics Unit, Department of Genetics, Institut Curie, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Biology Department, Institut Gustave Roussy, Villejuif, France. · APHP Pathology Department, Hôpital Saint Louis, Paris Diderot University, Paris, France. · Pathology Department, Hôpital René-Huguenin, Institut Curie, Saint-Cloud, France. · Pathology Department, Institut Gustave Roussy, Villejuif, France. · Pathology Department, Institut Curie, Paris, France. · APHP, Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Pubmed 27592112
  • Institut E3M-ICAN, Department of Endocrinology and Reproductive Medicine (Z.C., C.C., V.Gr., I.T., P.T.), Hôpitaux Universitaires Pitié Salpêtrière Charles Foix, Centre des Pathologies Gynécologiques Rares, Firendo, Université Pierre et Marie Curie, 75013 Paris, France · Department of Oncological Surgery (F.L.), Institut Curie, 75005 Paris, France · Inserm (M.B., I.C., A.C., N.P., S.B., F.B., P.C., J.-E.G., V.G., P.T.), U1151, Institut Necker Enfants Malades, 75993 Paris, France · Université Paris Descartes (M.B., I.C., A.C., N.P., S.B., F.B., M.F., M.D.C., R.P., J.-E. G., V.G.), Sorbonne Paris Cité, France · Department of Genetics (I.B., S.V.), Institut Curie, 75005 Paris, France · Unite de Recherche Clinique (M.-L.T., A.B.), Pitie Salpêtriere Hospital, 75013 Paris, France · Inserm (M.F., M.D.C.), U1016, Institut Cochin, 75014 Paris, France · CNRS (M.F., M.D.C., R.P.), UMR8104, Paris, France · Inter Régional pour la Santé (F.R., J.T.), La Riche, France · and Department of Pathology (B.S.-Z.), Institut Curie, 75005 Paris, France. · Pubmed 27575941
  • Translational Research Department, Laboratory of Preclinical Investigation, Institut Curie, PSL University, Paris, France. · Institut Roche, Boulogne-Billancourt, France. · Department of Pathology, Institut Curie, Paris, France. · Platform of Molecular Biology Facilities, Institut Curie, PSL University, Paris, France. · Flow Cytometry Core Facility, Institut Curie, PSL University, Paris, France. · GenoSplice Technology, Institut Universitaire d'Hématologie, Paris, France. · Inserm, U830, Institut Curie, PSL University, Paris, France. · CNRS UMR3306, INSERM U1005, Institut Curie, PSL University, Orsay, France. · Department of Medical Oncology, Institut Curie, Institut Curie, Paris, France. · Roche Diagnostics GmbH, Penzberg, Germany. · Translational Research Department, Institut Curie, PSL University, Paris, France. · Pubmed 27388901
  • Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Translational Research, Institut Curie, Paris, France. · QIAGEN Marseille SA, Marseille, France. · Residual Tumor and Response to Treatment Team, Institut Curie, Department of Translational Research, Paris, France. · Pubmed 26829108
  • Centre De Recherche, Institut Curie, Paris, F-75248, France. · INSERM U830, Paris, F-75248, France. · Département De Biologie Des Tumeurs, Institut Curie, Paris, F-75248, France. · Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, K7L 3N6, Canada. · Centre De Ressources Biologiques, Institut Curie, Paris, F-75248, France. · Département De Recherche Translationnelle, Institut Curie, Paris, F-75248, France. · Sorbonne Paris Cité, University Paris-Descartes, Paris, F-75270, France. · Pubmed 26317927
  • Psycho-Oncology Unit, Supportive Care Department, Institute Curie, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · Psychology Institute, LPPS EA 4057, University Paris Descartes, Boulogne Billancourt, France. · EA 4275, Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Sciences, University of Nantes, Nantes, France. · Institute of High School in Osteopathy, Laboratory of Osteopathy Research, Nantes, France. · Tumor Biology Department, Institut Curie, Paris, France. · Psycho-Oncology Unit, Supportive Care Department, Institute Curie, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · Psychology Institute, LPPS EA 4057, University Paris Descartes, Boulogne Billancourt, France. · Inserm, U 669, Paris, France. · University Paris-Sud and UMR-S0669, University Paris Descartes, Paris, France. · Unit of Methodology and Biostatistics, University Hospital of Nantes, Nantes, France. · Pubmed 26076962
2015
  • INSERM U932, Institut Curie, Paris, France. Institut Curie, Department of Immunology, Paris, France. · UMR144 CNRS, Institut Curie, Paris, France. Institut Curie, Department of Surgical Oncology, Paris, France. · Université Lyon 1, Lyon, France. INSERM U1052/CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Centre Léon Bérard, Lyon, France. · Institut Curie, Department of Pathology, Paris, France. · Institut Curie, Department of Surgical Oncology, Paris, France. · INSERM U932, Institut Curie, Paris, France. Institut Curie, Department of Immunology, Paris, France. Center of Clinical Investigations, Curie-IGR, Paris-Villejuif, France. · Pubmed 25977333
  • Psycho-Oncology Unit, Supportive Care Department, Institute Curie, Paris, France. · Psychology Institute, LPPS EA 4057, University Paris Descartes, Paris, France. · Inter-Psy, Lorraine University, Nancy, France. · Tumour Biology Department, Institut Curie, Paris, France. · Inserm, Paris, France. · University Paris-Sud and UMR-S0669, Paris, France. · University Paris Descartes, Paris, France. · Pubmed 25976423
2014
  • Centre for Computational Biology, Mines ParisTech, Fontainebleau, France; Institut Curie, Paris, France; U900, INSERM, Paris, France. · UMR144, Oncology Molecular Team, Institut Curie, Paris, France; Department of translational research, Residual Tumor and Response to Treatment Team, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Radiotherapy, Institut Curie, Paris, France. · UMR144, Oncology Molecular Team, Institut Curie, Paris, France; Department of translational research, Residual Tumor and Response to Treatment Team, Institut Curie, Paris, France; Department of Surgery, Institut Curie, Paris, France. · Pubmed 25098247
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Department of Radiology, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 24714751
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Radiology, Institut Curie, Paris, France. · Department of Tumors' Biology, Institut Curie, Paris, France. · Department of Radiotherapy, Institut Curie, Paris, France. · Pubmed 24388733
2013
  • Department of Biostatistics, Curie Institute, Paris 75248, France; Inserm U900, Curie Institute, Paris 75248, France. · Pubmed 24095610
  • Institut Curie, Centre de Recherche, Paris, France; INSERM U830, Paris, France; Department of Tumor Biology, Institut Curie, Paris, France. · Pubmed 23754601
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23526930
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23051951
2012
  • Department of Tumor Biology, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France. · Pubmed 22711610
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 21907436
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23056641
  • Department of Tumor Biology, Institut Curie, 26 rue d'ULM, 75248 Paris Cedex 05, France. · Pubmed 22531230
  • Département de chirurgie, Institut Curie, Paris, France. · Pubmed 22529987
  • Department of Radiation Oncology, Institut Curie, 26 rue d'Ulm, Paris, 75005, France. · Pubmed 22438050
  • Institut Curie, CNRS, Paris, France. · Pubmed 22271875
  • Department of Medical Oncology, Institut Curie, 26 rue d’Ulm, Paris Cedex 05, France. · Pubmed 21358298
2011
  • Department of tumour Biology, Institut Curie, Paris 75005, France. · Pubmed 21631949
  • Department of Biostatistics, Institut Curie, Paris, France. · Pubmed 22087319
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 21655258
2010
  • Preclinical Investigation Unit, Institut Curie - Translational Research Department, Hôpital St Louis, Quadrilatère historique, Porte 13, 1, Ave Claude Vellefaux, Paris 75010, France. · Pubmed 20877358
INSERM France
2016
  • Translational Research Department, Laboratory of Preclinical Investigation, Institut Curie, PSL University, Paris, France. · Institut Roche, Boulogne-Billancourt, France. · Department of Pathology, Institut Curie, Paris, France. · Platform of Molecular Biology Facilities, Institut Curie, PSL University, Paris, France. · Flow Cytometry Core Facility, Institut Curie, PSL University, Paris, France. · GenoSplice Technology, Institut Universitaire d'Hématologie, Paris, France. · Inserm, U830, Institut Curie, PSL University, Paris, France. · CNRS UMR3306, INSERM U1005, Institut Curie, PSL University, Orsay, France. · Department of Medical Oncology, Institut Curie, Institut Curie, Paris, France. · Roche Diagnostics GmbH, Penzberg, Germany. · Translational Research Department, Institut Curie, PSL University, Paris, France. · Pubmed 27388901
2013
  • Department of Biostatistics, Curie Institute, Paris 75248, France; Inserm U900, Curie Institute, Paris 75248, France. · Pubmed 24095610
  • Institut Curie, Centre de Recherche, Paris, France; INSERM U830, Paris, France; Department of Tumor Biology, Institut Curie, Paris, France. · Pubmed 23754601
  • Institut National de la Santé et de la Recherche Medicale (Inserm), U1016, Institut Cochin, France. · Pubmed 23396587
2012
  • INSERM, Centre d'Investigations Cliniques-9501, CHU Nancy & Nancy-Université, 54511 Vandoeuvre-les-Nancy, France. · Pubmed 22048814
Sorbonne University
2016
  • Translational Research Department, Laboratory of Preclinical Investigation, Institut Curie, PSL University, Paris, France. · Institut Roche, Boulogne-Billancourt, France. · Department of Pathology, Institut Curie, Paris, France. · Platform of Molecular Biology Facilities, Institut Curie, PSL University, Paris, France. · Flow Cytometry Core Facility, Institut Curie, PSL University, Paris, France. · GenoSplice Technology, Institut Universitaire d'Hématologie, Paris, France. · Inserm, U830, Institut Curie, PSL University, Paris, France. · CNRS UMR3306, INSERM U1005, Institut Curie, PSL University, Orsay, France. · Department of Medical Oncology, Institut Curie, Institut Curie, Paris, France. · Roche Diagnostics GmbH, Penzberg, Germany. · Translational Research Department, Institut Curie, PSL University, Paris, France. · Pubmed 27388901
4 Other Locations Show
Yearly article counts 002624511310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.